论文部分内容阅读
由中国微生物学会干扰素学会(筹)举办、四川省微生物学会和卫生部成都生物制品研究所联合承办的第三次全国干扰素-病毒性肝炎学术会议于1992年10月12～14日在四川省成都市召开,来自全国10个省市自治区的48名代表出席了会议。会议共收到学术论文40余篇,在会议上报告的有17篇。在5型病毒性肝炎中,乙型肝炎和丙型肝炎问题最大、转慢性最多,与原发性肝癌的关系也最密切。对这二种肝炎目前尚无有设的治疗方法,因此应用干扰素或联合干扰素治疗已成为国内外医学界关注的问题。北京地坛医院应用美国先灵公司的重组干扰素-α26(干扰能),每日300万
The Third National Interferon-Viral Hepatitis Symposium was co-hosted by Interferon Society of China Society of Microbiology (chips), Sichuan Institute of Microbiology and Chengdu Institute of Biological Products of Ministry of Health. The symposium was held on October 12-14, 1992 in Sichuan Held in Chengdu, Sichuan Province, 48 delegates from 10 provinces, autonomous regions and municipalities across the country attended the meeting. The conference has received over 40 academic papers and 17 papers reported at the conference. Among the 5 types of viral hepatitis, hepatitis B and C are the most problematic, the most chronic and the most closely related to primary liver cancer. So far there is no cure for these two kinds of hepatitis, so the application of interferon or combined with interferon has become the concern of medical circles at home and abroad. Beijing Ditan Hospital using the United States Schering AG recombinant interferon-α26 (interference energy), 3 million daily